Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2401 AL 2415

Therapeutic potential of ferulic acid and its derivatives in Alzheimer's disease-A systematic review

Phadke AV, Tayade AA, Khambete MP.

Chem Biol Drug Des. 2021 Nov;98(5):713-721. doi: 10.1111/cbdd.13922. Epub 2021 Jul 16.

NM101 Phase III study of NE3107 in Alzheimer's disease: rationale, design and therapeutic modulation of neuroinflammation and insulin resistance

Reading CL, Ahlem CN, Murphy MF.

Neurodegener Dis Manag. 2021 Aug;11(4):289-298. doi: 10.2217/nmt-2021-0022. Epub 2021 Jul 12.

The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial

Mitchell SL, D'Agata EMC, Hanson LC, Loizeau AJ, Habtemariam DA, Tsai T, Anderson RA, Shaffer ML.

JAMA Intern Med. 2021 Sep 1;181(9):1174-1182. doi: 10.1001/jamainternmed.2021.3098.

The Current State of Pharma and the FDA: Approval of a Dementia Drug as a Case in Point

Eiser AR.

Am J Med. 2021 Dec;134(12):1442-1443. doi: 10.1016/j.amjmed.2021.06.014. Epub 2021 Jul 12.

FDA Approval of Aduhelm Paves a New Path for Alzheimer's Disease

Tanzi RE.

ACS Chem Neurosci. 2021 Aug 4;12(15):2714-2715. doi: 10.1021/acschemneuro.1c00394. Epub 2021 Jul 14.

Aducanumab for Alzheimer's disease: expediting approval and delaying science

Salinas RA.

BMJ Evid Based Med. 2021 Oct;26(5):214-215. doi: 10.1136/bmjebm-2021-111765. Epub 2021 Jul 14.

Chronic traumatic encephalopathy and the nucleus basalis of Meynert

Mufson EJ, Kelley C, Perez SE.

Handb Clin Neurol. 2021;182:9-29. doi: 10.1016/B978-0-12-819973-2.00002-2.

Mechanisms of amyloid proteins aggregation and their inhibition by antibodies, small molecule inhibitors, nano-particles and nano-bodies

Salahuddin P, Khan RH, Furkan M, Uversky VN, Islam Z, Fatima MT.

Int J Biol Macromol. 2021 Sep 1;186:580-590. doi: 10.1016/j.ijbiomac.2021.07.056. Epub 2021 Jul 14.

Efficacy and safety of pharmacotherapy for Alzheimer's disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials

Seibert M, Mühlbauer V, Holbrook J, Voigt-Radloff S, Brefka S, Dallmeier D, Denkinger M, Schönfeldt-Lecuona C, Klöppel S, von Arnim CAF.

Alzheimers Res Ther. 2021 Jul 16;13(1):131. doi: 10.1186/s13195-021-00867-8.

Recent advances in drug repurposing using machine learning

Urbina F, Puhl AC, Ekins S.

Curr Opin Chem Biol. 2021 Dec;65:74-84. doi: 10.1016/j.cbpa.2021.06.001. Epub 2021 Jul 16.

Photothermal and Photodynamic Therapies via NIR-Activated Nanoagents in Combating Alzheimer's Disease

Zeng F, Peng K, Han L, Yang J.

ACS Biomater Sci Eng. 2021 Aug 9;7(8):3573-3585. doi: 10.1021/acsbiomaterials.1c00605. Epub 2021 Jul 19.

Real-world Utilisation of the Rivastigmine Transdermal Patches Accompanying the Use of Risk Minimisation Tools in Patients with Dementia

Reinhardt F, Scarmeas N, Karan R, Veldandi UK, Modali S, Duvvuri K, Pathan RK.

Curr Alzheimer Res. 2021;18(4):273-282. doi: 10.2174/1567205018666210716120540.

Effects of Spices (Saffron, Rosemary, Cinnamon, Turmeric and Ginger) in Alzheimer's Disease

Seibel R, Schneider RH, Gottlieb MGV.

Curr Alzheimer Res. 2021;18(4):347-357. doi: 10.2174/1567205018666210716122034.

Defective Autophagy and Mitophagy in Alzheimer's Disease: Mechanisms and Translational Implications

Chen J, He HJ, Ye Q, Feng F, Wang WW, Gu Y, Han R, Xie C.

Mol Neurobiol. 2021 Oct;58(10):5289-5302. doi: 10.1007/s12035-021-02487-7. Epub 2021 Jul 19.

Aducanumab for Alzheimer's disease - too many unanswered questions

Phizackerley D.

Drug Ther Bull. 2021 Sep;59(9):130. doi: 10.1136/dtb.2021.000043. Epub 2021 Jul 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias